Biohit Oyj Stock Forecast for 2023 - 2025 - 2030

Updated on 04/18/2024

Stock Rating
0
Price Target
2.40€
Consensus
Outperform
Upside
17.07%
Analysts
0
Stock Rating
0
Upside
17.07%
Analysts
0
Price Target
2.40€

Biohit Oyj Stock Forecast and Price Target

The average target price for Biohit Oyj's stock set by renowned analysts in recent months is 2.40€, representing a potential upside of approximately 17.07% from its last closing price if met by 2025. This estimation is based on a high estimate of 2.40€ and a low estimate of 2.40€.

2.40€

17.07% Upside

Buy
Buy

Biohit Oyj Fair Value Forecast for 2023 - 2025 - 2030

In the last year, Biohit Oyj's Price has fallen from 1.80€ to 0.00€ – a 100.00% decrease. In the next year, analysts expect Fair Value to reach 0.00€ – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.

2025 Fair Value Forecast
0.00€
2026 Fair Value Forecast
0.00€
2027 Fair Value Forecast
0.00€
2028 Fair Value Forecast
0.00€
2029 Fair Value Forecast
0.00€
2030 Fair Value Forecast
0.00€

Biohit Oyj Revenue Forecast for 2023 - 2025 - 2030

Biohit Oyj's Revenue has increased by 83.99% In the last three years, going from 7.12€M to 13.10€M. According to 0 prominent analysts, Biohit Oyj's Revenue will fall by 18.29% in the next year, reaching 10.70€M. By 2030, professionals believe that Biohit Oyj's Revenue will decrease by 16.88%, reaching 10.89€M – a concerning trend for the company.

2024 Rev Forecast
0.01€B
2025 Rev Forecast
0.01€B
2026 Rev Forecast
0.01€B
2027 Rev Forecast
0.01€B
2028 Rev Forecast
0.01€B
2029 Rev Forecast
0.01€B
2030 Rev Forecast
0.01€B

Biohit Oyj Dividend per Share Forecast for 2023 - 2025 - 2030

Biohit Oyj Free Cash Flow Forecast for 2023 - 2025 - 2030

Biohit Oyj EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Biohit Oyj's EBITDA has grown from -1.39€M to 2.00€M – a 243.88% increase. In the next year, 0 analysts estimate that Biohit Oyj's EBITDA will decrease by 273.40%, reaching -3.47€M. According to professional forecasts, in 2030, Biohit Oyj's EBITDA will decrease by 376.76%, reaching -5.54€M.

2024 EBITDA Forecast
-3467933.33€
2025 EBITDA Forecast
-3951478.84€
2026 EBITDA Forecast
-5432361.39€
2027 EBITDA Forecast
-7572168.54€
2028 EBITDA Forecast
-5861868.07€
2029 EBITDA Forecast
-5347196.06€
2030 EBITDA Forecast
-5535239.12€

Biohit Oyj EBIT Forecast for 2023 - 2025 - 2030

In the last three years, Biohit Oyj's EBIT has grown by 150.47%, rising from -3.17€M to 1.60€M. According to 0 analysts, Biohit Oyj's EBIT will fall by 50.26% in the next year, reaching 795.79€k. Professionals believe that By 2030, Biohit Oyj's EBIT will fall to 746.91€k – a 53.32% decrease from its current value.

2024 EBIT Forecast
795.79€k
2025 EBIT Forecast
368.56€k
2026 EBIT Forecast
599.03€k
2027 EBIT Forecast
955.47€k
2028 EBIT Forecast
0.00€B
2029 EBIT Forecast
767.05€k
2030 EBIT Forecast
746.91€k

Biohit Oyj EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, Biohit Oyj's EPS has fallen from 0.12€ to 0.00€ – a 100.00% decrease. In the next year, analysts expect EPS to reach 0.00€ – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.

2025 EPS Forecast
0.00€
2026 EPS Forecast
0.00€
2027 EPS Forecast
0.00€
2028 EPS Forecast
0.00€
2029 EPS Forecast
0.00€
2030 EPS Forecast
0.00€